Distributed 7 August 2019
In light of recent communications from Health Canada
regarding the provision of cell therapy treatments, this message is intended to
clarify the preparation of platelet rich plasma treatments in dentistry.
Key information for dental patients regarding platelet rich
Key information for
CDSBC registrants regarding platelet rich plasma:
conducted by “practitioners,” including physicians and dentists;
obtained from a patient; and
administered back to the same patient in a single procedure.
As with any treatment, informed consent must be obtained from the patient before proceeding, and the College’s Infection Prevention and Control Guidelines be adhered to.
In May, Health Canada issued a safety update to Canadians
about the potential health risks associated with unauthorized cell therapy
treatments, stating that all cell therapies are considered drugs under the Food
and Drugs Act and must, therefore, be authorized by Health Canada to ensure
that they are safe and effective before they can be offered to Canadians. The
initial communication did not specifically address the provision of
platelet-rich plasma to dental patients; however, a clarification of Health
Canada’s position on platelet rich plasma treatments was issued on July 26.
Read the clarification, which speaks directly to PRP treatments >>
Enquiries can be directed to Health Canada at 613-957-2991